Advisory Committee on the Medical Uses of Isotopes: Meeting Notice, 18655 [2015-07990]

Download as PDF Federal Register / Vol. 80, No. 66 / Tuesday, April 7, 2015 / Notices Nominations are due on or before June 8, 2015. DATES: Submit an electronic copy of resume or curriculum vitae to Ms. Sophie Holiday, Sophie.Holiday@nrc.gov. Please ensure that the resume or curriculum vitae includes the following information, if applicable: Education; certification; professional association membership and committee membership activities; duties and responsibilities in current and previous clinical, research, and/or academic position(s). FOR FURTHER INFORMATION CONTACT: Ms. Sophie Holiday, U.S. Nuclear Regulatory Commission, Office of Nuclear Material Safety and Safeguards; telephone (404) 997–4691; email: Sophie.Holiday@nrc.gov. SUPPLEMENTARY INFORMATION: The ACMUI Nuclear Pharmacist provides advice on issues associated with the regulation of nuclear pharmacy applications of byproduct material. This advice includes providing input on NRC proposed rules and guidance, providing recommendations on the training and experience requirements for Authorized Nuclear Pharmacists, identifying medical events associated with these uses, evaluating non-routine uses of byproduct material, bringing key issues in the nuclear pharmacy community to the attention of NRC staff, as they relate to radiopharmaceuticals, radiation safety and NRC medical-use policy. ACMUI members are selected based on their educational background, certification(s), work experience, involvement and/or leadership in professional society activities, and other information obtained in letters or during the selection process. ACMUI members possess the medical and technical skills needed to address evolving issues. The current membership is comprised of the following professionals: (a) Nuclear medicine physician; (b) nuclear cardiologist; (c) two radiation oncologists; (d) diagnostic radiologist; (e) therapy medical physicist; (f) nuclear medicine physicist; (g) nuclear pharmacist; (h) health care administrator; (i) radiation safety officer; (j) patients’ rights advocate; (k) Food and Drug Administration representative; and (l) Agreement State representative. NRC is inviting nominations for the Nuclear Pharmacist to the ACMUI. The term of the individual currently occupying this position will end March 29, 2016. Committee members currently serve a four-year term and may be considered for reappointment to an additional term. mstockstill on DSK4VPTVN1PROD with NOTICES NOMINATION PROCESS: VerDate Sep<11>2014 17:46 Apr 06, 2015 Jkt 235001 Nominees must be U.S. citizens and be able to devote approximately 160 hours per year to Committee business. Members who are not Federal employees are compensated for their service. In addition, members are reimbursed for travel (including perdiem in lieu of subsistence) and are reimbursed secretarial and correspondence expenses. Full-time Federal employees are reimbursed travel expenses only. Security Background Check: The selected nominee will undergo a thorough security background check. Security paperwork may take the nominee several weeks to complete. Nominees will also be required to complete a financial disclosure statement to avoid conflicts of interest. Dated at Rockville, Maryland, this 1st day of April, 2015. For the U.S. Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 2015–07993 Filed 4–6–15; 8:45 am] BILLING CODE CODE 7590–01–P NUCLEAR REGULATORY COMMISSION Advisory Committee on the Medical Uses of Isotopes: Meeting Notice U.S. Nuclear Regulatory Commission. ACTION: Notice of meeting. AGENCY: The U.S. Nuclear Regulatory Commission will convene a teleconference meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on June 16, 2015, to discuss the ACMUI Radioactive Seed Localization subcommittee report and to hear a presentation from Spectrum Pharmaceuticals regarding the training and experience requirements for alpha and beta emitters. Meeting information, including a copy of the agenda and handouts, will be available at https:// www.nrc.gov/reading-rm/doccollections/acmui/meetings/2015.html. The agenda and handouts may also be obtained by contacting Ms. Sophie Holiday using the information below. DATES: The teleconference meeting will be held on Tuesday, June 16, 2015, 2:00 p.m. to 5:00 p.m. Eastern Standard Time. Public Participation: Any member of the public who wishes to participate in the teleconference should contact Ms. Holiday using the contact information below. FOR FURTHER INFORMATION CONTACT: Ms. Sophie Holiday, U.S. Nuclear SUMMARY: PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 18655 Regulatory Commission, Office of Nuclear Material Safety and Safeguards; telephone: (404) 997–4691, email: sophie.holiday@nrc.gov. Conduct of the Meeting Dr. Bruce Thomadsen, ACMUI Chairman, will preside over the meeting. Dr. Thomadsen will conduct the meeting in a manner that will facilitate the orderly conduct of business. The following procedures apply to public participation in the meeting: 1. Persons who wish to provide a written statement should submit an electronic copy to Ms. Holiday at the contact information listed above. All submittals must be received by June 11, 2015, three business days prior to the meeting, and must pertain to the topic on the agenda for the meeting. 2. Questions and comments from members of the public will be permitted during the meetings, at the discretion of the Chairman. 3. The draft transcript and meeting summary will be available on ACMUI’s Web site https://www.nrc.gov/readingrm/doc-collections/acmui/meetings/ 2015.html on or about July 29, 2015. This meeting will be held in accordance with the Atomic Energy Act of 1954, as amended (primarily Section 161a); the Federal Advisory Committee Act (5 U.S.C. App); and the Commission’s regulations in Title 10 of the Code of Federal Regulations Part 7. Dated at Rockville, Maryland, this 1st day of April, 2015. For the U.S. Nuclear Regulatory Commission. Andrew L. Bates, Advisory Committee Management Officer. [FR Doc. 2015–07990 Filed 4–6–15; 8:45 am] BILLING CODE CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2015–0058] Applications and Amendments to Facility Operating Licenses and Combined Licenses Involving Proposed No Significant Hazards Considerations and Containing Sensitive Unclassified Non-Safeguards Information and Order Imposing Procedures for Access to Sensitive Unclassified Non-Safeguards Information Nuclear Regulatory Commission. ACTION: License amendment request; opportunity to comment, request a AGENCY: E:\FR\FM\07APN1.SGM 07APN1

Agencies

[Federal Register Volume 80, Number 66 (Tuesday, April 7, 2015)]
[Notices]
[Page 18655]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-07990]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION


Advisory Committee on the Medical Uses of Isotopes: Meeting 
Notice

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission will convene a 
teleconference meeting of the Advisory Committee on the Medical Uses of 
Isotopes (ACMUI) on June 16, 2015, to discuss the ACMUI Radioactive 
Seed Localization subcommittee report and to hear a presentation from 
Spectrum Pharmaceuticals regarding the training and experience 
requirements for alpha and beta emitters. Meeting information, 
including a copy of the agenda and handouts, will be available at 
https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2015.html. 
The agenda and handouts may also be obtained by contacting Ms. Sophie 
Holiday using the information below.

DATES: The teleconference meeting will be held on Tuesday, June 16, 
2015, 2:00 p.m. to 5:00 p.m. Eastern Standard Time.
    Public Participation: Any member of the public who wishes to 
participate in the teleconference should contact Ms. Holiday using the 
contact information below.

FOR FURTHER INFORMATION CONTACT: Ms. Sophie Holiday, U.S. Nuclear 
Regulatory Commission, Office of Nuclear Material Safety and 
Safeguards; telephone: (404) 997-4691, email: sophie.holiday@nrc.gov.

Conduct of the Meeting

    Dr. Bruce Thomadsen, ACMUI Chairman, will preside over the meeting. 
Dr. Thomadsen will conduct the meeting in a manner that will facilitate 
the orderly conduct of business. The following procedures apply to 
public participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Holiday at the contact information listed above. 
All submittals must be received by June 11, 2015, three business days 
prior to the meeting, and must pertain to the topic on the agenda for 
the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meetings, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site https://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2015.html on or about July 29, 2015.
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10 of the Code of Federal Regulations Part 7.

    Dated at Rockville, Maryland, this 1st day of April, 2015.


    For the U.S. Nuclear Regulatory Commission.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2015-07990 Filed 4-6-15; 8:45 am]
BILLING CODE CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.